{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:08Z","timestamp":1789055168914,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015627","name":"Quest Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM104938"],"award-info":[{"award-number":["U54GM104938"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajog.2021.03.048","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T08:41:01Z","timestamp":1618908061000},"page":"280.e1-280.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome"],"prefix":"10.1016","volume":"225","author":[{"given":"Sushila","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.03.048_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.03.048_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.03.048_bib6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2021.03.048_bib7","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012","volume":"14","author":"Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ajog.2021.03.048_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/REP-09-0568","article-title":"The adverse effects of obesity on conception and implantation","volume":"140","author":"Brewer","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2021.03.048_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.fertnstert.2017.02.114","article-title":"Adverse effects of female obesity and interaction with race on reproductive potential","volume":"107","author":"Luke","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2021.03.048_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2021.03.048_bib12","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1093\/humrep\/des308","article-title":"The association between severe obesity and characteristics of failed fertilized oocytes","volume":"27","author":"Machtinger","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.03.048_bib13","doi-asserted-by":"crossref","first-page":"138.e1","DOI":"10.1016\/j.ajog.2019.03.011","article-title":"Influence of metabolic syndrome on female fertility and in\u00a0vitro fertilization outcomes in PCOS women","volume":"221","author":"He","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.048_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.03.048_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2012.04.027","article-title":"High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice","volume":"98","author":"Veltman-Verhulst","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2021.03.048_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2003.09.036","article-title":"The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome","volume":"113","author":"Sahin","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2021.03.048_bib18","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.fertnstert.2011.05.048","article-title":"Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.03.048_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2021.03.048_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cct.2011.12.005","article-title":"The Pregnancy in polycystic ovary syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome","volume":"33","author":"Legro","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ajog.2021.03.048_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2021.03.048_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","article-title":"The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial","volume":"101","author":"Legro","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2021.03.048_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-7-17","article-title":"On the use of a continuous metabolic syndrome score in pediatric research","volume":"7","author":"Eisenmann","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajog.2021.03.048_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A\u00a0modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2021.03.048_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajog.2021.03.048_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of gestational diabetes and risk of progression to Type 2 diabetes: a global perspective","volume":"16","author":"Zhu","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajog.2021.03.048_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2021.03.048_bib31","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.03.048_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/aje\/kwp211","article-title":"Metabolic syndrome in early pregnancy and risk of preterm birth","volume":"170","author":"Chatzi","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2021.03.048_bib33","doi-asserted-by":"crossref","first-page":"362.e1","DOI":"10.1016\/j.ajog.2015.01.027","article-title":"Weight gain in pregnancy: does the Institute of Medicine have it right?","volume":"212","author":"Truong","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.048_bib34","first-page":"412","article-title":"Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis","volume":"70","author":"Lau","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2021.03.048_bib35","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2014-1214","article-title":"Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"99","author":"Palomba","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.03.048_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1471-0528.12558","article-title":"Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia","volume":"121","author":"Naver","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.03.048_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08559-w","article-title":"The effect of androgen excess on maternal metabolism, placental function and fetal growth in obese dams","volume":"7","author":"Fornes","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2021.03.048_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2021.03.048_bib39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.metabol.2007.06.020","article-title":"Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity","volume":"56","author":"S\u00e1nchez-Vera","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2021.03.048_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2021.03.048_bib41","doi-asserted-by":"crossref","first-page":"482.e1","DOI":"10.1016\/j.ajog.2009.05.032","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study","volume":"201","author":"Wiznitzer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.048_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.23736\/S0026-4784.18.04330-7","article-title":"Dyslipidemia in pregnancy and maternal-fetal outcome","volume":"71","author":"Nasioudis","year":"2019","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ajog.2021.03.048_bib43","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2337\/diab.28.12.1064","article-title":"Chronic hyperinsulinemia in the fetal rhesus monkey: effects on hepatic enzymes active in lipogenesis and carbohydrate metabolism","volume":"28","author":"McCormick","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.ajog.2021.03.048_bib44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2337\/dc13-1934","article-title":"Normalizing metabolism in diabetic pregnancy: is it time to target lipids?","volume":"37","author":"Barrett","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2021.03.048_bib45","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/oby.22246","article-title":"Postprandial triglycerides predict newborn fat more strongly than glucose in women with obesity in early pregnancy","volume":"26","author":"Barbour","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajog.2021.03.048_bib46","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.clinthera.2018.08.007","article-title":"Maternal lipids and fetal overgrowth: making fat from fat","volume":"40","author":"Barbour","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajog.2021.03.048_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajog.2017.05.040","article-title":"Gestational weight gain","volume":"217","author":"Kominiarek","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.03.048_bib48","series-title":"Weight gain during pregnancy: reexamining the guidelines","article-title":"The National Academies Collection: Reports funded by National Institutes of Health","year":"2009"},{"key":"10.1016\/j.ajog.2021.03.048_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.03.048_bib50","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2021.03.048_bib51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.whi.2011.03.006","article-title":"Preconception health of low socioeconomic status women: assessing knowledge and behaviors","volume":"21","author":"Harelick","year":"2011","journal-title":"Womens Health Issues"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821004476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821004476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:35:56Z","timestamp":1762079756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821004476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0002937821004476"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.03.048","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}